OFTOL PLUS

This brand name is authorized in Ecuador

Active ingredients

The drug OFTOL PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1 Loteprednol
UNII YEH1EZ96K6 - LOTEPREDNOL ETABONATE

Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure.

Read about Loteprednol
2 Tobramycin
UNII VZ8RRZ51VK - TOBRAMYCIN

Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations.

Read about Tobramycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S02CA Corticosteroids and antiinfectives in combination S Sensory organs → S02 Otologicals → S02C Corticosteroids and antiinfectives in combination
Discover more medicines within S02CA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 2434-MEE-0916

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.